Outcome of patients with relapsed or refractory chronic lymphocytic leukemia treated with flavopiridol: Impact of genetic features

导出原文传递

翻译打印收藏纠错

作者： Woyach,J.A. ^[1] ; Lozanski,G. ^[2] ; Ruppert,A.S. ^[3] ; Lozanski,A. ; Blum,K.A. ; Jones,J.A. ; Flynn,J.M. ; Johnson,A.J. ; Grever,M.R. ; Heerema,N.A. ; Byrd,J.C.

作者单位： Division of Cytogenetics, Department of Pathology, Ohio State University, Columbus, OH, United ^[1] Department of Pathology, Ohio State University, Columbus, OH, United States ^[2] Division of Hematology, Department of Internal Medicine and Comprehensive Cancer Center, Ohio State ^[3]

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Leukemia

2012年26卷6期

1442-1444页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Outcome of patients with relapsed or refractory chronic lymphocytic leukemia treated with flavopiridol: Impact of genetic features

Leukemia

相似文献

Leukemia

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Outcome of patients with relapsed or refractory chronic lymphocytic leukemia treated with flavopiridol: Impact of genetic features

Leukemia

相似文献

Leukemia

相关期刊

检索历史清除